(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NAP1L1 mRNA] CTD PMID:31150632 1,2-dimethylhydrazine multiple interactions ISO Nap1l1 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NAP1L1 mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression ISO Nap1l1 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of NAP1L1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO Nap1l1 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NAP1L1 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Nap1l1 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of NAP1L1 mRNA and [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NAP1L1 mRNA CTD PMID:16214954 and PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of NAP1L1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Nap1l1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of NAP1L1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of NAP1L1 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Nap1l1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of NAP1L1 mRNA CTD PMID:19770486 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of NAP1L1 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of NAP1L1 mRNA CTD PMID:21346803 2-amino-14,16-dimethyloctadecan-3-ol decreases expression ISO NAP1L1 (Homo sapiens) 6480464 2-amino-14 and 16-dimethyloctadecan-3-ol results in decreased expression of NAP1L1 protein CTD PMID:32044396 2-methylcholine affects expression ISO NAP1L1 (Homo sapiens) 6480464 beta-methylcholine affects the expression of NAP1L1 mRNA CTD PMID:21179406 2-nitrofluorene increases expression EXP 6480464 2-nitrofluorene results in increased expression of NAP1L1 mRNA CTD PMID:15890375 3,3',5,5'-tetrabromobisphenol A decreases expression ISO NAP1L1 (Homo sapiens) 6480464 tetrabromobisphenol A results in decreased expression of NAP1L1 protein CTD PMID:31675489 3,4-methylenedioxymethamphetamine decreases expression ISO Nap1l1 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of NAP1L1 mRNA CTD PMID:26251327 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO NAP1L1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NAP1L1 mRNA CTD PMID:28628672 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1 and 2-dithiol-3-thione results in decreased expression of NAP1L1 mRNA CTD PMID:19162173 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of NAP1L1 mRNA CTD PMID:15890375 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2 and 6-dinitrotoluene affects the expression of NAP1L1 mRNA CTD PMID:21346803 4-hydroxyphenyl retinamide decreases expression ISO Nap1l1 (Mus musculus) 6480464 Fenretinide results in decreased expression of NAP1L1 mRNA CTD PMID:28973697 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of NAP1L1 mRNA CTD PMID:19483382 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of NAP1L1 mRNA CTD PMID:19483382 aflatoxin B1 decreases expression ISO Nap1l1 (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of NAP1L1 mRNA CTD PMID:19770486 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of NAP1L1 mRNA CTD PMID:15890375 aflatoxin M1 decreases expression ISO NAP1L1 (Homo sapiens) 6480464 Aflatoxin M1 results in decreased expression of NAP1L1 mRNA CTD PMID:30928695 all-trans-retinoic acid decreases expression ISO NAP1L1 (Homo sapiens) 6480464 Tretinoin results in decreased expression of NAP1L1 mRNA CTD PMID:15498508 and PMID:33167477 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of NAP1L1 mRNA CTD PMID:19483382 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of NAP1L1 mRNA CTD PMID:16483693 aristolochic acid A decreases expression ISO NAP1L1 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of NAP1L1 mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO Nap1l1 (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of NAP1L1 mRNA CTD PMID:23650126 arsenite(3-) multiple interactions ISO NAP1L1 (Homo sapiens) 6480464 arsenite promotes the reaction [G3BP1 protein binds to NAP1L1 protein] CTD PMID:32406909 arsenous acid increases expression ISO NAP1L1 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of NAP1L1 mRNA CTD PMID:20458559 benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of NAP1L1 mRNA CTD PMID:19483382 benzo[a]pyrene decreases expression ISO Nap1l1 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of NAP1L1 mRNA CTD PMID:19770486 benzo[a]pyrene increases expression ISO Nap1l1 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of NAP1L1 mRNA CTD PMID:22228805 bisphenol A decreases expression ISO Nap1l1 (Mus musculus) 6480464 bisphenol A results in decreased expression of NAP1L1 mRNA CTD PMID:23798566 bisphenol A decreases expression ISO NAP1L1 (Homo sapiens) 6480464 bisphenol A results in decreased expression of NAP1L1 protein CTD PMID:34186270 bisphenol A multiple interactions ISO NAP1L1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NAP1L1 mRNA CTD PMID:28628672 bisphenol A decreases methylation ISO Nap1l1 (Mus musculus) 6480464 bisphenol A results in decreased methylation of NAP1L1 promoter CTD PMID:27312807 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of NAP1L1 mRNA CTD PMID:25181051 bisphenol F increases expression ISO NAP1L1 (Homo sapiens) 6480464 bisphenol F results in increased expression of NAP1L1 protein CTD PMID:34186270 bleomycin A2 decreases expression ISO Nap1l1 (Mus musculus) 6480464 Bleomycin results in decreased expression of NAP1L1 protein CTD PMID:29733421 Brodifacoum increases expression EXP 6480464 bromfenacoum results in increased expression of NAP1L1 protein CTD PMID:28903499 butyric acid decreases expression ISO NAP1L1 (Homo sapiens) 6480464 Butyric Acid results in decreased expression of NAP1L1 protein CTD PMID:34581912 cadmium atom multiple interactions ISO NAP1L1 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NAP1L1 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO NAP1L1 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NAP1L1 mRNA CTD PMID:35301059 caffeine decreases phosphorylation ISO NAP1L1 (Homo sapiens) 6480464 Caffeine results in decreased phosphorylation of NAP1L1 protein CTD PMID:35688186 calcitriol decreases expression ISO NAP1L1 (Homo sapiens) 6480464 Calcitriol results in decreased expression of NAP1L1 mRNA CTD PMID:12798352 carbon nanotube decreases expression ISO Nap1l1 (Mus musculus) 6480464 Nanotubes and Carbon results in decreased expression of NAP1L1 mRNA CTD PMID:25554681 choline multiple interactions ISO Nap1l1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NAP1L1 gene CTD PMID:20938992 chromium(6+) affects expression ISO Nap1l1 (Mus musculus) 6480464 chromium hexavalent ion affects the expression of NAP1L1 mRNA CTD PMID:28472532 clofibrate affects expression EXP 6480464 Clofibrate affects the expression of NAP1L1 mRNA CTD PMID:19483382 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of NAP1L1 mRNA CTD PMID:17602206 cobalt dichloride increases expression ISO NAP1L1 (Homo sapiens) 6480464 cobaltous chloride results in increased expression of NAP1L1 mRNA CTD PMID:19376846 copper(II) sulfate decreases expression ISO NAP1L1 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of NAP1L1 mRNA CTD PMID:19549813 coumarin affects phosphorylation ISO NAP1L1 (Homo sapiens) 6480464 coumarin affects the phosphorylation of NAP1L1 protein CTD PMID:35688186 cyclosporin A increases expression ISO NAP1L1 (Homo sapiens) 6480464 Cyclosporine results in increased expression of NAP1L1 mRNA CTD PMID:20106945 cyclosporin A decreases expression ISO NAP1L1 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of NAP1L1 mRNA CTD PMID:27989131 cyclosporin A affects expression ISO Nap1l1 (Mus musculus) 6480464 Cyclosporine affects the expression of NAP1L1 mRNA CTD PMID:19770486 dexamethasone multiple interactions ISO NAP1L1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NAP1L1 mRNA CTD PMID:28628672 diarsenic trioxide increases expression ISO NAP1L1 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of NAP1L1 mRNA CTD PMID:20458559 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of NAP1L1 mRNA CTD PMID:21266533 dicrotophos decreases expression ISO NAP1L1 (Homo sapiens) 6480464 dicrotophos results in decreased expression of NAP1L1 mRNA CTD PMID:28302478 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of NAP1L1 mRNA CTD PMID:15890375 disodium selenite increases expression ISO NAP1L1 (Homo sapiens) 6480464 Sodium Selenite results in increased expression of NAP1L1 mRNA CTD PMID:18175754 diuron increases expression EXP 6480464 Diuron results in increased expression of NAP1L1 mRNA CTD PMID:21551480 diuron decreases expression ISO NAP1L1 (Homo sapiens) 6480464 Diuron results in decreased expression of NAP1L1 mRNA CTD PMID:35967413 doxorubicin affects expression ISO NAP1L1 (Homo sapiens) 6480464 Doxorubicin affects the expression of NAP1L1 protein CTD PMID:29385562 doxorubicin increases expression ISO NAP1L1 (Homo sapiens) 6480464 Doxorubicin results in increased expression of NAP1L1 mRNA CTD PMID:29803840 enzyme inhibitor multiple interactions ISO NAP1L1 (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NAP1L1 protein CTD PMID:23301498 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of NAP1L1 protein CTD PMID:24646710 ethanol affects splicing ISO Nap1l1 (Mus musculus) 6480464 Ethanol affects the splicing of NAP1L1 mRNA CTD PMID:30319688 ethyl methanesulfonate decreases expression ISO NAP1L1 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of NAP1L1 mRNA CTD PMID:23649840 etoposide affects response to substance ISO NAP1L1 (Homo sapiens) 6480464 NAP1L1 protein affects the susceptibility to Etoposide CTD PMID:16217747 finasteride increases expression EXP 6480464 Finasteride results in increased expression of NAP1L1 mRNA CTD PMID:24136188 fipronil increases expression EXP 6480464 fipronil results in increased expression of NAP1L1 mRNA CTD PMID:23962444 flutamide increases expression EXP 6480464 Flutamide results in increased expression of NAP1L1 mRNA CTD PMID:24136188 folic acid multiple interactions ISO Nap1l1 (Mus musculus) 6480464 [1 more ... CTD PMID:20938992 and PMID:22206623 formaldehyde decreases expression ISO NAP1L1 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of NAP1L1 mRNA CTD PMID:23649840 FR900359 increases phosphorylation ISO NAP1L1 (Homo sapiens) 6480464 FR900359 results in increased phosphorylation of NAP1L1 protein CTD PMID:37730182 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of NAP1L1 mRNA CTD PMID:22061828 hydralazine multiple interactions ISO NAP1L1 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of NAP1L1 mRNA CTD PMID:17183730 hydrogen peroxide affects expression ISO NAP1L1 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of NAP1L1 mRNA CTD PMID:21179406 hydrogen peroxide decreases expression ISO NAP1L1 (Homo sapiens) 6480464 Hydrogen Peroxide results in decreased expression of NAP1L1 protein CTD PMID:34581912 indometacin multiple interactions ISO NAP1L1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NAP1L1 mRNA CTD PMID:28628672 ivermectin decreases expression ISO NAP1L1 (Homo sapiens) 6480464 Ivermectin results in decreased expression of NAP1L1 protein CTD PMID:32959892 L-ethionine affects expression EXP 6480464 Ethionine affects the expression of NAP1L1 mRNA CTD PMID:19483382 L-methionine multiple interactions ISO Nap1l1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NAP1L1 gene CTD PMID:20938992 mercury atom increases expression ISO NAP1L1 (Homo sapiens) 6480464 Mercury results in increased expression of NAP1L1 mRNA CTD PMID:16823088 mercury(0) increases expression ISO NAP1L1 (Homo sapiens) 6480464 Mercury results in increased expression of NAP1L1 mRNA CTD PMID:16823088 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of NAP1L1 mRNA CTD PMID:15890375 methyl methanesulfonate decreases expression ISO NAP1L1 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of NAP1L1 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO NAP1L1 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of NAP1L1 mRNA CTD PMID:28001369 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of NAP1L1 gene CTD PMID:33148267 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of NAP1L1 mRNA and [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of NAP1L1 mRNA CTD PMID:17602206 and PMID:28943392 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of NAP1L1 mRNA CTD PMID:15890375 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of NAP1L1 mRNA CTD PMID:24136188 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of NAP1L1 mRNA CTD PMID:24136188 omeprazole affects expression EXP 6480464 Omeprazole affects the expression of NAP1L1 mRNA CTD PMID:19483382 paracetamol affects expression ISO Nap1l1 (Mus musculus) 6480464 Acetaminophen affects the expression of NAP1L1 mRNA CTD PMID:17562736 paracetamol increases expression ISO NAP1L1 (Homo sapiens) 6480464 Acetaminophen results in increased expression of NAP1L1 mRNA CTD PMID:22230336 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of NAP1L1 mRNA CTD PMID:17202762 and PMID:32479839 pentachlorophenol increases expression ISO Nap1l1 (Mus musculus) 6480464 Pentachlorophenol results in increased expression of NAP1L1 mRNA CTD PMID:23892564 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of NAP1L1 mRNA CTD PMID:19162173 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of NAP1L1 gene CTD PMID:33148267 phenobarbital affects expression ISO NAP1L1 (Homo sapiens) 6480464 Phenobarbital affects the expression of NAP1L1 mRNA CTD PMID:19159669 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of NAP1L1 mRNA CTD PMID:15890375 and PMID:22484513 pirinixic acid decreases expression ISO Nap1l1 (Mus musculus) 6480464 pirinixic acid results in decreased expression of NAP1L1 mRNA CTD PMID:17426115 pirinixic acid increases expression ISO Nap1l1 (Mus musculus) 6480464 pirinixic acid results in increased expression of NAP1L1 mRNA CTD PMID:17950772 more ... pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of NAP1L1 mRNA CTD PMID:15890375 more ... pirinixic acid multiple interactions ISO Nap1l1 (Mus musculus) 6480464 PPARA protein promotes the reaction [pirinixic acid results in increased expression of NAP1L1 mRNA] CTD PMID:17950772 and PMID:20059764 pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of NAP1L1 mRNA CTD PMID:19483382 piroxicam increases expression ISO NAP1L1 (Homo sapiens) 6480464 Piroxicam results in increased expression of NAP1L1 mRNA CTD PMID:21858171 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of NAP1L1 mRNA CTD PMID:19162173 pyrogallol increases expression ISO Nap1l1 (Mus musculus) 6480464 Pyrogallol results in increased expression of NAP1L1 mRNA CTD PMID:20362636 rimonabant multiple interactions ISO Nap1l1 (Mus musculus) 6480464 Rimonabant inhibits the reaction [Dietary Fats results in increased expression of NAP1L1 mRNA] CTD PMID:19030233 SB 431542 multiple interactions ISO NAP1L1 (Homo sapiens) 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of NAP1L1 protein CTD PMID:37664457 sevoflurane decreases expression ISO Nap1l1 (Mus musculus) 6480464 Sevoflurane results in decreased expression of NAP1L1 protein CTD PMID:35249202 silicon dioxide decreases expression ISO Nap1l1 (Mus musculus) 6480464 Silicon Dioxide results in decreased expression of NAP1L1 mRNA CTD PMID:19073995 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of NAP1L1 mRNA CTD PMID:19072884 sodium arsenite decreases expression ISO NAP1L1 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of NAP1L1 protein CTD PMID:30528433 sodium fluoride decreases expression ISO Nap1l1 (Mus musculus) 6480464 Sodium Fluoride results in decreased expression of NAP1L1 mRNA CTD PMID:27862939 sulindac decreases expression ISO NAP1L1 (Homo sapiens) 6480464 Sulindac results in decreased expression of NAP1L1 mRNA CTD PMID:11507085 sunitinib increases expression ISO NAP1L1 (Homo sapiens) 6480464 Sunitinib results in increased expression of NAP1L1 mRNA CTD PMID:31533062 tamibarotene decreases expression ISO NAP1L1 (Homo sapiens) 6480464 tamibarotene results in decreased expression of NAP1L1 mRNA CTD PMID:15498508 tert-butyl hydroperoxide decreases expression ISO NAP1L1 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in decreased expression of NAP1L1 mRNA CTD PMID:15336504 tetrachloromethane increases expression ISO Nap1l1 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of NAP1L1 mRNA CTD PMID:27339419 and PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NAP1L1 mRNA] CTD PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of NAP1L1 mRNA CTD PMID:31150632 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of NAP1L1 mRNA CTD PMID:19483382 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of NAP1L1 mRNA CTD PMID:34492290 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of NAP1L1 mRNA CTD PMID:28943392 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of NAP1L1 mRNA CTD PMID:30589522 uranium atom affects expression ISO NAP1L1 (Homo sapiens) 6480464 Uranium affects the expression of NAP1L1 mRNA CTD PMID:15672453 ursodeoxycholic acid affects expression ISO NAP1L1 (Homo sapiens) 6480464 Ursodeoxycholic Acid affects the expression of NAP1L1 mRNA CTD PMID:18422935 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of NAP1L1 mRNA CTD PMID:24136188 valproic acid affects expression ISO Nap1l1 (Mus musculus) 6480464 Valproic Acid affects the expression of NAP1L1 mRNA CTD PMID:17292431 valproic acid multiple interactions ISO NAP1L1 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of NAP1L1 mRNA CTD PMID:17183730 valproic acid decreases expression ISO Nap1l1 (Mus musculus) 6480464 Valproic Acid results in decreased expression of NAP1L1 mRNA CTD PMID:19136453 valproic acid affects expression ISO NAP1L1 (Homo sapiens) 6480464 Valproic Acid affects the expression of NAP1L1 mRNA CTD PMID:25979313 valproic acid decreases expression ISO NAP1L1 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of NAP1L1 mRNA CTD PMID:23179753 more ...